174 related articles for article (PubMed ID: 38551031)
21. Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinoma.
Christgen M; Kandt LD; Antonopoulos W; Bartels S; Van Bockstal MR; Bredt M; Brito MJ; Christgen H; Colpaert C; Cserni B; Cserni G; Daemmrich ME; Danebrock R; Dedeurwaerdere F; van Deurzen CH; Erber R; Fathke C; Feist H; Fiche M; Gonzalez CA; Ter Hoeve ND; Kooreman L; Krech T; Kristiansen G; Kulka J; Laenger F; Lafos M; Lehmann U; Martin-Martinez MD; Mueller S; Pelz E; Raap M; Ravarino A; Reineke-Plaass T; Schaumann N; Schelfhout AM; De Schepper M; Schlue J; Van de Vijver K; Waelput W; Wellmann A; Graeser M; Gluz O; Kuemmel S; Nitz U; Harbeck N; Desmedt C; Floris G; Derksen PW; van Diest PJ; Vincent-Salomon A; Kreipe H
J Pathol Clin Res; 2022 Mar; 8(2):191-205. PubMed ID: 34889530
[TBL] [Abstract][Full Text] [Related]
22. Mammary collagen is under reproductive control with implications for breast cancer.
Guo Q; Sun D; Barrett AS; Jindal S; Pennock ND; Conklin MW; Xia Z; Mitchell E; Samatham R; Mirza N; Jacques S; Weinmann S; Borges VF; Hansen KC; Schedin PJ
Matrix Biol; 2022 Jan; 105():104-126. PubMed ID: 34839002
[TBL] [Abstract][Full Text] [Related]
23. Atlas of Lobular Breast Cancer Models: Challenges and Strategic Directions.
Sflomos G; Schipper K; Koorman T; Fitzpatrick A; Oesterreich S; Lee AV; Jonkers J; Brunton VG; Christgen M; Isacke C; Derksen PWB; Brisken C
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771558
[TBL] [Abstract][Full Text] [Related]
24. Mammary collagen architecture and its association with mammographic density and lesion severity among women undergoing image-guided breast biopsy.
Bodelon C; Mullooly M; Pfeiffer RM; Fan S; Abubakar M; Lenz P; Vacek PM; Weaver DL; Herschorn SD; Johnson JM; Sprague BL; Hewitt S; Shepherd J; Malkov S; Keely PJ; Eliceiri KW; Sherman ME; Conklin MW; Gierach GL
Breast Cancer Res; 2021 Nov; 23(1):105. PubMed ID: 34753492
[TBL] [Abstract][Full Text] [Related]
25. Leptomeningeal carcinomatosis and breast cancer: a systematic review of current evidence on diagnosis, treatment and prognosis.
Mollica L; Leli C; Puglisi S; Sardi S; Sottotetti F
Drugs Context; 2021; 10():. PubMed ID: 34745272
[TBL] [Abstract][Full Text] [Related]
26. Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: A population-based analysis.
van Maaren MC; Ávila AO; van Manen JG; Menke-Pluijmers MB; Veltman J; Bart J; Westenend PJ; Siesling S
Breast; 2021 Oct; 59():376-382. PubMed ID: 34428722
[TBL] [Abstract][Full Text] [Related]
27. Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations.
Conforti F; Pala L; Pagan E; Rocco EG; Bagnardi V; Montagna E; Peruzzotti G; De Pas T; Fumagalli C; Pileggi S; Pesenti C; Marchini S; Corso G; Marchio' C; Sapino A; Graffeo R; Collet L; Aftimos P; Sotiriou C; Piccart M; Gelber RD; Viale G; Colleoni M; Goldhirsch A
Breast; 2021 Oct; 59():94-101. PubMed ID: 34217971
[TBL] [Abstract][Full Text] [Related]
28. Contraceptive progestins with androgenic properties stimulate breast epithelial cell proliferation.
Shamseddin M; De Martino F; Constantin C; Scabia V; Lancelot AS; Laszlo C; Ayyannan A; Battista L; Raffoul W; Gailloud-Matthieu MC; Bucher P; Fiche M; Ambrosini G; Sflomos G; Brisken C
EMBO Mol Med; 2021 Jul; 13(7):e14314. PubMed ID: 34042278
[TBL] [Abstract][Full Text] [Related]
29. Mediator of DNA Damage Checkpoint 1 (MDC1) Is a Novel Estrogen Receptor Coregulator in Invasive Lobular Carcinoma of the Breast.
Sottnik JL; Bordeaux EK; Mehrotra S; Ferrara SE; Goodspeed AE; Costello JC; Sikora MJ
Mol Cancer Res; 2021 Aug; 19(8):1270-1282. PubMed ID: 33947745
[TBL] [Abstract][Full Text] [Related]
30. Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutations.
Bergeron A; MacGrogan G; Bertaut A; Ladoire S; Arveux P; Desmoulins I; Bonnefoi H; Loustalot C; Auriol S; Beltjens F; Degrolard-Courcet E; Charon-Barra C; Richard C; Boidot R; Arnould L
Mod Pathol; 2021 Jul; 34(7):1282-1296. PubMed ID: 33753865
[TBL] [Abstract][Full Text] [Related]
31. Intraductal xenografts show lobular carcinoma cells rely on their own extracellular matrix and LOXL1.
Sflomos G; Battista L; Aouad P; De Martino F; Scabia V; Stravodimou A; Ayyanan A; Ifticene-Treboux A; ; Bucher P; Fiche M; Ambrosini G; Brisken C
EMBO Mol Med; 2021 Mar; 13(3):e13180. PubMed ID: 33616307
[TBL] [Abstract][Full Text] [Related]
32. Association of a Diagnosis of Ductal Carcinoma In Situ With Death From Breast Cancer.
Giannakeas V; Sopik V; Narod SA
JAMA Netw Open; 2020 Sep; 3(9):e2017124. PubMed ID: 32936299
[TBL] [Abstract][Full Text] [Related]
33. The clinical significance of oestrogen receptor expression in breast ductal carcinoma in situ.
Miligy IM; Toss MS; Shiino S; Oni G; Syed BM; Khout H; Tan QT; Green AR; Macmillan RD; Robertson JFR; Rakha EA
Br J Cancer; 2020 Nov; 123(10):1513-1520. PubMed ID: 32773767
[TBL] [Abstract][Full Text] [Related]
34. Invasive Lobular Breast Cancer as a Distinct Disease: Implications for Therapeutic Strategy.
Luveta J; Parks RM; Heery DM; Cheung KL; Johnston SJ
Oncol Ther; 2020 Jun; 8(1):1-11. PubMed ID: 32700069
[TBL] [Abstract][Full Text] [Related]
35. Differential Regulation and Targeting of Estrogen Receptor α Turnover in Invasive Lobular Breast Carcinoma.
Sreekumar S; Levine KM; Sikora MJ; Chen J; Tasdemir N; Carter D; Dabbs DJ; Meier C; Basudan A; Boone D; McAuliffe PF; Jankowitz RC; Lee AV; Atkinson JM; Oesterreich S
Endocrinology; 2020 Sep; 161(9):. PubMed ID: 32609836
[TBL] [Abstract][Full Text] [Related]
36. Levonorgestrel-releasing intrauterine system and breast cancer risk: A systematic review and meta-analysis.
Conz L; Mota BS; Bahamondes L; Teixeira Dória M; Françoise Mauricette Derchain S; Rieira R; Sarian LO
Acta Obstet Gynecol Scand; 2020 Aug; 99(8):970-982. PubMed ID: 31990981
[TBL] [Abstract][Full Text] [Related]
37. Do Body Mass Index and Breast Density Impact Cancer Risk Among Women with Lobular Carcinoma In Situ?
Minami CA; Zabor EC; Gilbert E; Newman A; Park A; Jochelson MS; King TA; Pilewskie ML
Ann Surg Oncol; 2020 Jun; 27(6):1844-1851. PubMed ID: 31898097
[TBL] [Abstract][Full Text] [Related]
38. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.
Collaborative Group on Hormonal Factors in Breast Cancer
Lancet; 2019 Sep; 394(10204):1159-1168. PubMed ID: 31474332
[TBL] [Abstract][Full Text] [Related]
39. Reproductive risk factor associations with lobular and ductal carcinoma in the Carolina Breast Cancer Study.
Williams LA; Nichols HB; Hoadley KA; Tse CK; Geradts J; Bell ME; Perou CM; Love MI; Olshan AF; Troester MA
Cancer Causes Control; 2018 Jan; 29(1):25-32. PubMed ID: 29124544
[TBL] [Abstract][Full Text] [Related]
40. Distinct Pattern of Metastases in Patients with Invasive Lobular Carcinoma of the Breast.
Mathew A; Rajagopal PS; Villgran V; Sandhu GS; Jankowitz RC; Jacob M; Rosenzweig M; Oesterreich S; Brufsky A
Geburtshilfe Frauenheilkd; 2017 Jun; 77(6):660-666. PubMed ID: 28757653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
